Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
NCT02592057
·
clinicaltrials.gov ↗
COMPLETED
Status
532
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C Virus
Interventions
DRUG:
SOF
Sponsor
Gilead Sciences